The Urine cytology market players and analysis by product, by indication, by end user - global forecast till 2030. The global urine cytology market is growing continuously and expected to grow at a CAGR of 10.20% from 2022 to 2030.

Cancer and urinary tract infections are both diagnosed using urine cytology analysis as a diagnostic tool. One of the most crucial diagnostic tests for individuals who have inexplicable blood in the urine, burning, or pain while urinating is this one.

Market expansion is fueled by rising demand for diagnostic tools and technology for the diagnosis of chronic diseases as well as rising rates of cancer and chronic illnesses. The existence of significant manufacturers engaged in the manufacturing of medical equipment also contributes to the market's expansion. There are now more diagnostic facilities worldwide as a result of growing demand for diagnostic testing in hospitals. The industry is growing in part because home care diagnostic services are so widely used. Market expansion is, however, constrained by pricy diagnostic techniques and rivalry among the top industry players.

According to cancer research U.K, 14.1 million of new cancer cases were registered globally which is increasing continuously. Due to the deteriorating lifestyle, smoking, and alcoholism are responsible for increasing prevalence of cancer.

The global urine cytology market is expected to grow at a CAGR of 10.20% during the forecast period.

Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Urine Cytology market research report–Global forecast till 2030.”

Major Players in Urine Cytology Market

Some of the key players in the global market are ThermoFischer Scientific (U.S.), BD (U.S.), Sigma- Aldrich (U.S.), Severn Biotech Limited (U.K), Bio-Techne (U.S.), Laboratory Corporation of America Holdings (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and others.

Segmentation

The global urine cytology market is segmented on the basis of product, indication, and end user.

On the basis of product, market is segmented into urine cytology instrument, urine cytology kit, and others. Product is further segmented into automated, and manual instrument.

On the basis of indication, the market is segmented into urinary infection, inflammatory disease, cancer, and others. Cancer is further segmented into kidney, bladder, ureter, and urethra.

On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, home care, and others.

Regional Analysis

In the Americas, rising prevalence of various types of allergies, arthritis, tendinitis, and others, and rising demand for corticosteroid injection in the U.S. are key driver for the growth of the market. According to survey of National Center for Chronic Disease Prevention and Health Promotion (CDC) in the U.S. every year 7 out of 10 individuals die due to chronic diseases and 86% of healthcare costs in the country. Additionally, increasing demand for diagnostic services, and automated sample processing devices also fuel the growth of the market.

Europe is the second largest market for urine cytology owing to the rising prevalence of cancer in European countries and availability of funds for research and development activities.

The market in Asia Pacific is expected to grow at the fastest pace and is driven increasing healthcare expenditure, and China, and India are the leading countries with increasing prevalence of infectious diseases. Additionally, rising awareness about urine cytology among healthcare provider and patient, increasing demand for diagnostics devices also influence the growth of the market. The key players in the market are now focusing on geographical expansion in developing regions of Asia Pacific.

The Middle East & Africa also show a steady rise in the market owing to high prevalence of chronic diseases, and increasing healthcare expenditure also influences the market growth in the Middle East & African countries. There is an increasing demand for diagnostic services in African countries owing to growing emphasis on women and child healthcare, and rising awareness about diagnosis and treatment of cancer and infectious diseases.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com